Claro Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-5,134
| Closed | -$575K | – | 326 |
|
2022
Q1 | $575K | Hold |
5,134
| – | – | 0.21% | 133 |
|
2021
Q4 | $575K | Buy |
5,134
+22
| +0.4% | +$2.46K | 0.21% | 133 |
|
2021
Q3 | $643K | Buy |
5,112
+306
| +6% | +$38.5K | 0.27% | 105 |
|
2021
Q2 | $651K | Buy |
4,806
+657
| +16% | +$89K | 0.29% | 94 |
|
2021
Q1 | $563K | Buy |
+4,149
| New | +$563K | 0.29% | 94 |
|